October 13, 2026

Federal Concerns Over Synthetically Concentrated Kratom Derivatives

Federal Concerns Over Synthetically Concentrated Kratom Derivatives

The spread of products derived from the kratom plant, particularly those known as ‘gas station opioid’ products, is raising alarms among federal authorities and lawmakers. These products are often sold at gas stations and tobacco shops.

The Drug Enforcement Administration (DEA) has expressed increased concern over kratom-derived extracts. Earlier this year, they announced plans to temporarily ban products containing high concentrations of compounds like 7-hydroxymitragynine (7-OH), mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16. This step aims to classify these substances as Schedule I under the Controlled Substances Act. Importantly, this action will not affect the natural herbal form of kratom that is available over the counter.

Kratom’s legality varies by state. Nine states have completely banned it, while more than 30 states regulate its sale with limits on 7-OH concentrations. In over a dozen states, kratom exists in a legal gray area without strict regulation.

Since around 2010, products with synthetically concentrated extracts, such as 7-OH, have become widely accessible. They often contain compounds that naturally occur in trace amounts in the kratom plant. Oliver Grundmann, a clinical professor at the University of Florida, supports the scheduling of these products. He notes that a Schedule I classification means the drug has no accepted medical use, which aligns with current knowledge about 7-OH.

Determining any medical use would involve the Food and Drug Administration’s (FDA) approval process. ‘That is clearly not what any of these manufacturers want to do,’ Grundmann said. ‘Therefore, placing 7-OH into the controlled substances schedule is appropriate, given our current understanding.’

Essential Healthcare Policy Developments

Key policies impacting healthcare this week and beyond include Pennsylvania’s report of its sixth death connected to a measles case. The state is dealing with the highest number of cases nationally. The coroner in Franklin County advised that the deceased, a 39-year-old woman, had underlying conditions but died after being treated for measles.

Research involving GLP-1 drugs suggests changes in adults with moderate-to-severe psoriasis and obesity. A study by Eli Lilly found notable immune and metabolic changes when treated with both Taltz (ixekizumab) and Zepbound (tirzepatide) compared to using Taltz alone.

Another study of British adults indicated no substantial difference in weight loss or maintenance between those consuming water or diet soft drinks.

Additional Health News

Current events include Congo’s Ebola outbreak reaching 5,000 cases, spreading at a rapid pace that outstrips efforts to control it. In Virginia, a proposed amendment on reproductive health may influence state abortion laws according to legal experts.

Iowa’s Senate candidates focus on healthcare in their campaigns, while Missouri hospitals deal with workforce challenges amid rising turnover rates.

Health News Highlights

  • Surveys show Americans have greater trust in science compared to global peers.
  • A study links HPV vaccination in women to reduced pregnancy risks.
  • Aging U.S. doctors prompt concerns over patient safety.
TAGS: